A Phase Ib/II Study of Eribulin in Combination With Cyclophosphamide in Patients With Solid Tumor Malignancies.
Phase of Trial: Phase I/II
Latest Information Update: 31 Jan 2018
At a glance
- Drugs Eribulin (Primary) ; Cyclophosphamide
- Indications Advanced breast cancer; Male breast cancer; Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 25 Jan 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.
- 10 Jun 2017 Biomarkers information updated
- 12 May 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2019.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History